Tresiba is a Type 2 diabetes insulin that is a long-acting insulin. It provides extended blood sugar control for patients struggling to get A1C hemoglobin test scores down to the standard 7% acceptable threshold when regulating blood sugar levels. This insulin pen is administered as a subcutaneous injection, and like other long-acting insulins the active ingredient – Degludec - functions throughout the day to help manage your blood sugar between meals and overnight by helping cells absorb more sugar from the bloodstream. Tresiba replaces your natural insulin for up to 42 hours.
Standard dosage for Tresiba insulin is to take 1 injection per day.
Injection may be administered into one of 3 acceptable injection sites: thighs / abdomen (but not within a 2” radius of navel) / back of upper arms.
Switch to a different injection site for each day’s injection, alternating between the 3 of them at all times to avoid the risk of lipodystrophy.
Take new pen out of fridge approximately 1 hour before planned injection.
Wash your hands.
Remove the pen cap and make sure the medication is clear and has no color.
Clean the rubber seal with an alcohol swab / attach a new pen needle for each injection.
Remove the paper tab and push the needle straight onto the pen.
Remove the outer pen needle cap and keep it for removing needle following injection.
Remove the inner needle cap and discard.
Turn the dose counter to 2 units and press the green injection button in fully until reading ‘0’ (zero) and check for a small amount of solution to come from the needle tip. This will need to be seen before you proceed with administering the injection.
Turn dose counter until correct prescribed dose is loaded / inject the dose.
At the injection site, insert the needle into your skin at a 90-degree angle / press the green injection button down completely and hold it until ‘0’ shows in dose window / count to 6 before releasing the injection button and removing the needle / release the injection button and remove the needle from your skin.
Remove and discard needle only as shown in your medication.
Store the pen at room temperature after the first use.
The active ingredient in Tresiba is Degludec.
Tell your doctor if you have any history of renal or hepatic impairment, heart failure, low blood potassium levels, edema or other forms of fluid retention before starting on Tresiba.
Medication is not recommended for the treatment of diabetic ketoacidosis.
Keep insulin t refrigerated at between 36°F to 46°F (2°C to 8°C) and at room temperature after first dose has been administered for each Tresiba Flextouch pen.
Be sure to change needles as indicated and do not remove outer cap on pen until you are ready and about to give yourself an injection.
There is the possibility of negative drug interaction risks between Tresiba and other Rx or OTC medications, including amlodipine / aspirin / atorvastatin / carvedilol / furosemide / gabapentin / empagliflozin / levothyroxine / lisinopril / losartan / metformin / metoprolol / Novolog (insulin aspart) / omeprazole / semaglutide / pantoprazole / rosuvastatin / dulaglutide / cholecalciferol.
Tell your doctor of all medications you are currently taking before receiving a medication and proceeding to buy Tresiba insulin online.
Side effects from using Tresiba are possible, and some users may experience diarrhea, headache, itching and rash at injection area, upper respiratory infections, or weight gain. If side effects are seen you may want to discontinue use and speak to your doctor again about insulin pen alternatives to Tresiba as part of Type 2 diabetes treatment.